A5089351824- Neurological Disorders and Treatments
- Acute Ischemic Stroke Management
- Cerebrovascular and Carotid Artery Diseases
- Parkinson's Disease Mechanisms and Treatments
- Traumatic Brain Injury and Neurovascular Disturbances
- Stroke Rehabilitation and Recovery
- Neurological disorders and treatments
- Cardiovascular Health and Disease Prevention
- Intracranial Aneurysms: Treatment and Complications
- Alzheimer's disease research and treatments
- Optical Imaging and Spectroscopy Techniques
- Neurology and Historical Studies
- Regional Development and Management Studies
- Neurological Disease Mechanisms and Treatments
- Genetic Neurodegenerative Diseases
- Neurological and metabolic disorders
- Dementia and Cognitive Impairment Research
- Cerebrovascular and genetic disorders
- Glioma Diagnosis and Treatment
- Lipoproteins and Cardiovascular Health
- Functional Brain Connectivity Studies
- Lipid Membrane Structure and Behavior
- Migraine and Headache Studies
- Cancer, Lipids, and Metabolism
- Transcranial Magnetic Stimulation Studies
University of Zagreb
2005-2023
Sisters of Charity Hospital
2005-2020
University Hospital Centre Zagreb
2012-2020
Opća Bolnica Zadar
2014
Ministry of Health
2008-2009
University of Ljubljana
2008
University of Padua
2008
<h3>Objective:</h3> To characterize effects of alemtuzumab treatment on measures disability improvement in patients with relapsing-remitting multiple sclerosis (RRMS) inadequate response (≥1 relapse) to prior therapy. <h3>Methods:</h3> Comparison Alemtuzumab and Rebif Efficacy Multiple Sclerosis (CARE-MS) II, a 2-year randomized, rater-blinded, active-controlled, head-to-head, phase 3 trial, compared efficacy safety 12 mg subcutaneous interferon-β-1a (SC IFN-β-1a) 44 μg RRMS. Prespecified...
Objectives: The aim of this randomized, double-blind, placebo-controlled trial was to determine the efficacy and safety Ginkgo biloba extract in patients diagnosed with vascular cognitive impairment (VCI). Methods: A total 90 (aged 67.1±8.0 years; 59 women) were randomly allocated (1:1:1) receive G. 120 mg, 60 or placebo during a 6-month period. Assessment made for indicators, including neuropsychological tests scores (Sandoz Clinical Geriatric Scale, Folstein Mini-Mental State Examination,...
Background: This research looks at the connection between psychological stress and prevalence of hand eczema (HE) among physicians dentists (surgeons, non-surgeons). Methods: cross-sectional field study involved 185 participants: non-surgeons), non-surgeons) controls. Hand lesions were examined using Osnabrueck Eczema Severity Index (OHSI), participants answered Nordic Occupational Skin Questionnaire (NOSQ) Perceived Stress Scale (PSS). Patch tests performed commercial contact allergens....
In Central/Eastern European countries, cerebrovascular diseases are among the leading causes of mortality. We aimed to determine incidence first-ever stroke (FES) in north-western part Croatia.A population-based prospective study was conducted between July 1, 2007, and June 30, 2009. Cases were sought from multiple overlapping sources. Incidence rates by type gender calculated.A total 1,487 events recorded, 1,017 which FESs. age-adjusted (per 100,000 population) were: FESs 223.6 [women/men...
Emotional disturbances in stroke patients may unfavorably affect the process of rehabilitation and longterm outcome disease.The aim study was to assess prevalence emotional their characteristics our patients, according hemispheric lateralization cerebral lesion (as recorded by CT), patient sex grade neurological handicap assessed Rankin scale).The included 50 (29 men 21 women, mean age 65.52 ± 7.07 64.62 11.83 years, respectively) who had suffered ischemic 3 weeks 6 months before study.The...